Jack Nathan Medical Corp.
JNHMF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $9 | $19 | $15 | $10 |
| % Growth | -54.5% | 23.6% | 60.7% | – |
| Cost of Goods Sold | $1 | $5 | $4 | $3 |
| Gross Profit | $7 | $14 | $12 | $7 |
| % Margin | 84.7% | 75.6% | 76.3% | 71.8% |
| R&D Expenses | $0 | $0 | $0 | $1 |
| G&A Expenses | $9 | $6 | $16 | $12 |
| SG&A Expenses | $9 | $7 | $17 | $13 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $14 | $0 | $1 |
| Operating Expenses | $10 | $21 | $17 | $14 |
| Operating Income | -$2 | -$2 | -$7 | -$8 |
| % Margin | -28.5% | -12% | -44.9% | -87.9% |
| Other Income/Exp. Net | -$0 | $0 | -$0 | $0 |
| Pre-Tax Income | -$3 | -$2 | -$7 | -$8 |
| Tax Expense | $0 | $1 | -$0 | -$0 |
| Net Income | $7 | -$7 | -$7 | -$8 |
| % Margin | 85.7% | -34.7% | -45.7% | -81% |
| EPS | -0.029 | -0.078 | -0.084 | -0.095 |
| % Growth | 62.5% | 7.6% | 11.5% | – |
| EPS Diluted | -0.03 | -0.078 | -0.084 | -0.095 |
| Weighted Avg Shares Out | 249 | 86 | 84 | 82 |
| Weighted Avg Shares Out Dil | 87 | 86 | 84 | 82 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $0 |
| EBITDA | -$2 | -$4 | -$4 | -$6 |
| % Margin | -17.7% | -22.5% | -28.5% | -63.3% |